Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centromere protein F (CENPF) is a large nuclear matrix protein critical for correct chromosome segregation during mitosis[1][2][6]. It localizes to the kinetochore in late G2 and maintains association through early anaphase, then relocates to the spindle midzone and intercellular bridge before degradation[1][2][6]. CENPF is essential for the assembly and function of the kinetochore complex and proper orientation of microtubules, influencing both cell division and the formation of cellular cilia[1][2]. Mutations in CENPF disrupt cell division and ciliogenesis, causing developmental disorders such as Strømme syndrome[1][2]. Autoantibodies to CENPF are observed in some cancers and graft-versus-host disease[1][2]. CENPF's pivotal role in mitosis and cell proliferation has stimulated interest as a potential therapeutic target in oncology, but no clinically approved drugs are currently directed at CENPF[5].
Not applicable; no approved drugs directly modulate CENPF. Hypothetically: Cell cycle inhibition, disruption of kinetochore-microtubule interactions, mitotic blockade
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centromere protein F (CENPF).